Last reviewed · How we verify
NCT04043026: RALiC
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
trial testing Statin in Atrial Fibrillation in 56 participants. Terminated before completion.
1 August 2022
Quick facts
| Lead sponsor | University of Liverpool |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 56 |
| Start date | 26 September 2019 |
| Primary completion | 1 August 2022 |
| Estimated completion | 1 August 2022 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Statin — full drug profile →
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Chronic Kidney Disease — all drugs for Chronic Kidney Disease →
Sponsor
University of Liverpool
Who can join
18 and older, any sex, with Atrial Fibrillation or Chronic Kidney Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is designed to investigate the role of lipids/lipoproteins as a potential cause for the harmful changes seen in fibrin clot properties with renal dysfunction and atrial fibrillation
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04043026
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Statin
Trials testing the same drug.
- NCT06902740 — PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis · Phase 4 · recruiting
- NCT06730802 — Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery · NA · not yet recruiting
- NCT06738758 — Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of · recruiting
- NCT06553157 — Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy · Phase 1, PHASE2 · completed
- NCT06520904 — Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography · Phase 4 · recruiting
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other University of Liverpool trials
Trials by the same sponsor.
- NCT07368881 — Fast Food Online Delivery Purchase Behaviour in the Presence and Absence of Price-based Incentives · NA · not yet recruiting
- NCT07339982 — Supermarket Labelling and Taxation Study · NA · not yet recruiting
- NCT07423845 — Nutri-score Labels on the Nutritional Quality of Out-of-home Food Selection · NA · recruiting
- NCT07339969 — Food Choice Among Individuals With an Eating Disorder Diagnosis · NA · recruiting
- NCT07103967 — Investigating the Effects of Calorie Information and Serving Size of Alcohol Products on Alcohol Consumption. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04043026 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Liverpool
- Last refreshed: 8 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04043026.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing